"Adding the Flex IPL system to our product line demonstrates our commitment to continue to offer the widest range of laser and light based products and technology solutions to our customers," said Gerard E. Puorro, President and Chief Executive Officer of Candela. "The Flex IPL system will enable us to continue our expansion into new markets with one of the most advanced IPL systems available today."
The Ellipse Flex features a unique Programmable Pulse Mode, which enables the clinician to design the output pulse of the device to fit almost any clinical situation presented. This allows the user to customize the treatment settings to each specific patient, enabling a more personalized treatment session.
"With the Ellipse Flex system, I have control of every output parameter," said Dr. Michael Drosner, Dermatologist, Cutaris Center, Munich, Germany. "Thanks to the unique Programmable Pulse Mode, I am able to fine tune treatment settings to a degree not possible with other IPL systems. This allows me to create a treatment profile that is specific for each patient. The patient's profile is easily saved for the patient's next visit, making each treatment experience consistent."
As with all Ellipse IPL systems, the Flex also features the patented Dual-Mode Filtering technology which removes potentially harmful "water absorbing" wavelengths from the output spectrum device. With other intense pulsed light technology, water absorbing wavelengths are absorbed everywhere in the skin creating a non-specific thermal injury, which can lead to an increased risk of side-effects. Dual Mode Filtering ensures only the wavelengths required to perform effective treatment are delivered to the skin, offering a safe, effective and lasting solution.
The new Ellipse Flex IPL system makes its debut as part of Candela's Pathways Program, featuring upgradeable technologies which provide practitioners with the flexibility to treat many patients with a variety of skin conditions.
About CANDELA:
Candela Corporation manufactures, and distributes innovative clinical solutions that enable physicians, surgeons, and personal care practitioners to treat selected cosmetic and medical conditions using lasers, aesthetic laser systems, and other advanced technologies. Founded near Boston in 1970, the company markets and services its products in over 64 countries from offices and distributors in the United States, Europe, Japan, China and other Asian locations. Candela established the aesthetic laser market 17 years ago, and currently has an installed base of 8,500 lasers worldwide. Candela is an Equal Opportunity and Affirmative Action Employer (Male/Female/Handicapped/Veteran). Visit Candela on the Web at http://www.candelalaser.com.
Safe Harbor Statement: Except for the historical information contained herein, this news release contains forward-looking statements that constitute Candela's current intentions, hopes, beliefs, expectations or predictions of the future, which are therefore inherently subject to risks and uncertainties. Such statements may relate to, among other things, our future revenue, gross margin, expense levels and earnings, our growth prospects, market acceptance of our products, the strength of our distribution channels, our ability to add new products, our ability to expand regulatory approvals and the liquidity of our common stock. The risks and uncertainties that may affect forward-looking statements include, among others: the cancellation or deferral of customer orders, dependence on a small number of strategic distribution relationships, difficulties in the timely development and market acceptance of new products, unanticipated increases in expenses, market developments that vary from the current public expectations concerning the growth of the laser industry, increased competitive pressures, changes in economic conditions, or difficulties in obtaining timely regulatory approvals. Further information on factors that could affect Candela's performance is included in Candela's periodic reports filed with the SEC, including but not limited to, Candela's Annual Report on Form 10-K for the year ended July 2, 2005, and subsequent Quarterly Reports on Form 10-Q. Candela cautions readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Candela expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any such statements to reflect any change in Candela's expectations or any change in events, conditions or circumstances on which any such statement is based.
© 2005 Business Wire
